20 Countries With Highest Rate of Epilepsy
In this article, we will take a detailed look at the 20 countries with the highest rates of epilepsy with insights into number of epilepsy cases by country and population.
Zynerba Pharmaceuticals Inc. (ZYNE)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fifth Lane Capital Cavan Copeland | 0 | $0 | 0% | |
| 2. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 3. | Beryl Capital Management David Alexander Witkin | 0 | $0 | 0% | |
| 4. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 5. | Highbridge Capital Management Glenn Russell Dubin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.43 | 5,000 | $32,153.00 | 5,000 | 2018-08-22 | Filing | |
| $5.96 | 15,000 | $89,422.50 | 352,512 | 2018-08-06 | Filing | |
| $5.80 | 3,800 | $22,047.60 | 43,693 | 2018-08-06 | Filing | |
| $5.79 | 3,800 | $22,013.40 | 182,546 | 2018-08-06 | Filing | |
| $5.97 | 8,518 | $50,842.24 | 20,718 | 2018-08-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.33 | 12,401 | $16,440.01 | 596,241 | 2023-09-13 | Filing | |
| $1.33 | 6,411 | $8,499.06 | 249,559 | 2023-09-13 | Filing | |
| $1.33 | 8,998 | $11,928.65 | 378,087 | 2023-09-13 | Filing | |
| $1.33 | 2,505 | $3,320.88 | 85,520 | 2023-09-13 | Filing | |
| $1.33 | 17,830 | $23,637.23 | 936,722 | 2023-09-13 | Filing |
Institutional Investors' Holdings
News See All
10 Best CBD Stocks to Invest In
In this article, we will take a look at the 10 best CBD stocks to invest in.
Should I Buy Zynerba Pharmaceuticals Inc (ZYNE)?
A whopping number of 13F filings filed with U.S.
Is Zynerba Pharmaceuticals (ZYNE) A Good Stock To Buy Now?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database.
Top 10 Cannabis Stocks To Buy Now
Cannabis has been illegal at a federal level in the US since 1970, when the Controlled Substances Act was passed by the Congress.
Zynerba Pharmaceuticals Inc (ZYNE): Hedge Funds Are Nibbling
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Do Hedge Funds Love Zynerba Pharmaceuticals Inc (ZYNE)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Fund and Insider Trading News: Dan Loeb, ValueAct Capital Management, Oracle Corporation (ORCL), Carvana Co. (CVNA), and More
Billionaire investor Dan Loeb said he’s increasing his short bets in anticipation of more market disruption.
Hedge Fund and Insider Trading News: Joseph Edelman, Accipiter Capital, EntreMed, Inc. (CASI), WideOpenWest Inc (WOW), National CineMedia, Inc. (NCMI), and More
The last time we checked in with Joseph Edelman, the founder, chief executive and portfolio manager of Perceptive Advisors and its hedge fund, Perceptive Life Sciences, he was buying stocks ahead of the...
Look Beyond Pharma to Invest in Marijuana Industry
In this article we are going to present an alternative to weed stocks such as GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Cara Therapeutics Inc (NASDAQ:CARA), Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE...
Hedge Fund Resource Center Billionaire Hedge Funds
